Aspire Biopharma Holdings, Inc. Warrant (ASBPW) Stock Price
ASBPWStock
$0.02
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta-1.38
ASBPW Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-35.22%
Price vs S&P 500 (4W)-38.05%
VGM Score23.99
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ASBPWAspire Biopharma Holdings, Inc. Warrant | — | — | D | $0.02 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About Aspire Biopharma Holdings, Inc. Warrant
Aspire Biopharma Holdings Inc develops nanotechnology-based drug delivery systems designed to administer pain and inflammation medications while bypassing the gastrointestinal tract. The company's proprietary formulation platform aims to provide alternatives to traditional oral medications, including opioid-based therapies. Its technology is intended to improve therapeutic outcomes and reduce medication-related risks.